Nanoparticle Organ Biodistribution Map (2D)

Inject a dose of nanoparticles and watch a real compartmental pharmacokinetic model route them between the bloodstream, liver, spleen, kidneys and a target tissue on a pannable, zoomable 2D organ map, with a live history chart tracking every compartment's share of the dose over time. Particle diameter, surface charge and PEG stealth-coating all feed directly into the governing rate constants — a small, neutral, heavily PEGylated particle clears through the kidneys in seconds, while a large, charged, uncoated one is swept up by the liver and spleen's macrophages and can linger for the entire simulation. This size/charge/coating trade-off is exactly the biodistribution uncertainty that drives real nanomedicine safety assessments and nanoethics debates about consent, long-term toxicity and equitable access to nanoscale therapies.